• Evotec SE EVO.OQ, EVO.O is expected to show a rise in quarterly revenue when it reports results on May 6 for the period ending March 31 2025

• The Hamburg-based company is expected to report a 8.1% increase in revenue to $244.85 million from $226.61 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Evotec SE is for a loss of 17 cents per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Evotec SE is $7.00​, above​ its last closing price of $4.23. ​​​

This summary was machine generated May 2 at 05:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)